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Objective: To define the prevalence and characteristics of associated congenital heart
diseases (CHDs) in patients with Hirschsprung’s disease (HSCR).
Method: All patients with a histological diagnosis of HSCR admitted to our hospital
between January 2010 and December 2013 were included in this prospective observa-
tional study and underwent cardiovascular screening. Cardiac anatomy was assessed by
a segmental echocardiographic approach. Measurements of aortic root and left ventricular
dimensions, wall thickness, and function were obtained. CHDs requiring a percutaneous
or surgical intervention were described as major heart diseases.
Results: One hundred thirty-three consecutive patients were enrolled at median age of
2.3 years. Eleven patients (8.3%) presented an associated heart disease. Moreover, five
patients had mild dilatation of aortic root. Six out of 11 (4.5%) patients had a major CHDs
requiring surgical repair.
Conclusion: Prevalence of associated CHDs was slightly higher than in previous papers,
and mostly represented by septal defects. Four out of six patients with major heart disease
had also a chromosomal anomaly. If we do not consider the subpopulation of patients with
a chromosomal anomaly, cardiac defects were present in 3.8% of the patients. Based on
these results, we suggest to perform routine echocardiogram in all Hirschsprung patients,
with or without associated chromosomal syndromes.
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INTRODUCTION
Hirschsprung’s disease (HSCR) is the commonest congenital gut
motility disorder and is characterized by the absence of ganglion
cells in a variable length of the distal gut. This results in absent peri-
stalsis in the affected bowel and it represents a frequent cause of
functional intestinal obstruction especially in the newborn period
(1–17). It occurs as a consequence of premature arrest of cranio-
caudal migration of neural crest-derived neuroblasts (NCN) in
the hindgut and is therefore described as a neurocristopathy (1,
17–19). Alterations of heterogenous genetic pathways involved in
the enteric nervous system development may interfere with the
colonization process of NCN and represents a primary etiology
both for HSCR and for the anomalies of other organs and systems
that often come together (13, 20–23).
According to literature, HSCR may be associated with a chro-
mosomal abnormality or additional congenital anomalies in
approximately 20% of cases (9, 16, 20, 21). Associated congen-
ital heart diseases (CHDs) have a reported incidence of around
5%. However, there could be an underestimation of the reported
incidence both because most of the studies were retrospective and
focused on genotype rather than on phenotype determination,
and because usually there is a mild or late symptoms onset with
subsequent missed or delayed diagnosis (9, 20, 21).
The aim of our study was to assess the prevalence and the
phenotype of associated CHDs in patients with HSCR.
MATERIALS AND METHODS
All consecutive HSCR patients admitted for further evaluation
and/or surgical treatment to the G. Gaslini Institute between
January 2010 and December 2013 were taken into account for
this prospective observational study. Only those with a histo-
logical diagnosis of intestinal aganglionosis were included in the
study and underwent cardiac screening (6). Exclusion criteria were
uncertain HSCR diagnosis and/or refusal to sign the Informed
Consent.
Enrolled patients and/or their parents were interviewed to
collect personal and family history, length of aganglionosis, and
any information regarding associated cardiac anomalies if already
detected during previous phenotype screening.
Length-wise, four types of aganglionosis have been identified:
short segment HSCR (S-HSCR) with aganglionosis extending
up to the left descending colon, long segment HSCR (L-HSCR)
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with aganglionosis extending up to the right transverse/ascending
colon, total colonic aganglionosis (TCA) with aganglionosis
extending to the whole colon with or without small bowel involve-
ment, and total intestinal aganglionosis (TIA) with aganglionosis
extending over the jejunum with <20 cm of normoganglionic
bowel (11).
For the purpose of our study, CHD was considered as “a gross
structural abnormality of the heart or intrathoracic great ves-
sels that is actually or potentially of functional significance,” as
defined by Mitchell et al. in 1971. Moreover, CHD requiring
a percutaneous or surgical intervention was described as major
CHD (5, 7).
The cardiovascular screening included physical examination
and an echocardiogram. Height, weight, and age were recorded in
each patient as well as the non-invasive blood pressure measure-
ment. Detailed echocardiograms were performed with a pulsed,
continuous, and color-Doppler provided ultrasound system (iE33,
Philips, Amsterdam, The Netherlands), using a 5 or 8 MHz trans-
ducer. Morphological variables were measured offline by two
observers (Giulia Tuo and Maria Derchi) who used the so-called
z-score for normalization of the cardiac structures dimensions to
the body size (4, 15, 24).
Cardiac anatomy was routinely assessed by a segmental
approach. Two-dimensional echocardiographic measurements
included the end-sistolic diameter, respectively, of the aortic annu-
lus, Valsalva sinuses, and ascending aorta. These dimensions were
measured from the parasternal long-axis view with the“inner edge
convention,” which uses the innermost bright edge reflection as a
contour. The aortic root was considered dilated if the z-score was
≥2 and the degree of dilation was defined mild if the z-score was
≤3 (15). End-diastolic wall thickness and left ventricular inter-
nal dimensions were measured through the M-mode technique,
which was performed also for calculating the shortening fraction.
Diastolic ventricular function and valves function were assessed
by both pulsed and continuous Doppler technique (2, 10, 12, 14).
For patients with a major CHD that required a trans-catheter
or surgical treatment, we reported both clinical and echocardio-
graphic details at the last follow-up examination.
Descriptive statistics were reported as percentages for categor-
ical variables and as mean± SD for continuous data. This study
was approved by our institutional Ethics Committee and informed
consent to view files, and echocardiographic reports was obtained
by the parents.
RESULTS
During the 5 years study period, 133 consecutive HSCR patients
were admitted to the Department of Surgery of the Gaslini Insti-
tute and underwent cardiac screening. Median age at enrollment
was 2.3 years (range 3 months to 25 years). Male to female ratio
was 4:1. Twenty patients (15%) had ultralong HSCR (either TCA
or TIA), 9 (7%) had L-HSCR, and 104 (78%) had S-HSCR. Eight
HSCR patients had also Down’s syndrome (6%).
Eleven patients (8.3%) presented an associated CHD of whom
six patients were already aware at the time of enrollment (Table 1).
Nine out of 11 were affected by the S-HSCR, 2/11 by the TCA.
5/11 (45%) were also affected by Down’s syndrome, and 1/11
by Turner’s syndrome. CHDs were mostly represented by septal
defects (atrial, ventricular, or atrioventricular septal defect) and
patent ductus arteriosus (Table 1). The family history was always
unremarkable for any CHD or arrhythmia. Six patients (4.5%)
presented a major CHD. Four out of six were also carrying a
chromosomal abnormality, and they all required a cardiac sur-
gical procedure. At a mean follow-up of 9 years (±5.8 years), they
were all asymptomatic and without any residual cardiac defects on
echocardiogram.
In addition to the above-mentioned abnormalities, we observed
mild dilatation of the aortic root in five patients. None of them had
an associated chromosomal abnormality. They are all being fol-
lowed up in the long term. None of the study population presented
high blood pressure.
DISCUSSION
Hirschsprung’s disease is the main genetic cause of functional
intestinal obstruction with an incidence of 1/5000 live births. It
is characterized by the absence of the enteric ganglia in a variable
length of the intestine, and it is the consequence of multiple gene
Table 1 | Details of HSCR patients with associated congenital heart diseases.
Patient Sex Age (m) Type of aganglionosis Type of heart disease Management Syndrome
1 M 59 S-HSCR Small OS ASD+ small PDA F-UP
2 M 58 S-HSCR Small OS ASD+ small PM VSD F-UP Down
3 F 54 S-HSCR Small OS ASD F-UP
4 M 51 S-HSCR Large OS ASD+moderate PM VSD SP
5 F 309 S-HSCR Large OP ASD SP Down
6 M 171 S-HSCR Large OS ASD+moderate PM VSD SP Down
7 M 192 TCA Large PM VSD SP Down
8 F 27 TCA AC SP Turner
9 M 96 S-HSCR Moderate size OS ASD SP
10 M 52 S-HSCR Small PDA F-UP Down
11 M 107 S-HSCR Small PDA F-UP
M, male; F, female; m, months of life at time of cardiac screening; S-HSCR, short segment Hirschsprung’s disease; TCA, total colonic aganglionosis; OS, ostium
secundum; OP, ostium primum; ASD, atrial septal defect; PM VSD, perimembranous ventricular septal defect; AC, aortic coarctation; PDA, patent ductus arteriosus;
F-UP, follow up; SP, surgical procedure.
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interactions, which affect the ability of the enteric neural crest cells
to differentiate in the developing gut (1, 13, 17–19, 22, 23).
Although HSCR occurs as an isolated phenotype in at least 70%
of cases, a number of associated congenital anomalies and syn-
dromes have been retrospectively reported. In particular, cardiac
defects occur with a mean incidence of 5% of cases of HSCR and,
among them, septation defects (atrial, ventricular, or atrioventric-
ular septal defect) and conotruncal developmental defects are the
most often described (8, 9, 16, 20, 21, 25, 26).
Among our study population, we had an overall detection rate
of associated CHDs of 8.3%, which is significantly higher than
prevalence reported by previous authors as the result of retro-
spective assessments of surgical series or of systematic literature
reviews (13, 20, 23). We may speculate that this discrepancy of
prevalence is due by the absence or mild severity of symptoms
related to the associated CHDs in most HSCR patients that may
lead to a misdiagnosis and/or a delayed diagnosis. In fact, 5/11
(45%) patients were diagnosed with an associated CHD only at
the time of our cardiac screening.
However, we could confirm literature data regarding the type of
detected CHDs, as they were mostly represented by septal defects.
This is in accordance to the embryologic role of neural crest-
derived stem cells in the development of both ENS and cardiac
outflow septation (9, 13, 18, 20, 21). Noteworthy, none of our
patients presented conotruncal heart defects whose pathogenesis
is similarly related to the abnormal neural crest cell prolifera-
tion and migration. On the other hand, five patients showed a
mild dilatation of the aortic root. To the best of our knowl-
edge, this echocardiographic finding has never been reported
before and we think that it would be worthy of further investi-
gations for understanding if there is some correlation between
this aortic wall anomaly and the multiple gene mutations involved
in HSCR.
Six out of 11 patients (5.4%) had a major CHD of whom
4 had also an associated chromosomal abnormality. The over-
all incidence of Down’s syndrome in our study population was
6% (8/133). Five out of eight patients (62%) with HSCR and
Down’s syndrome presented also an associated CHD that required
a surgical intervention in three cases. In 2009, the 30-years ret-
rospective nationwide survey carried out in Japan showed an
increased incidence of Down’s syndrome in patients affected by
HSCR and interestingly also an increased incidence of associ-
ated cardiac anomalies in the last 10 years (27). We believe it is
worth noting that Down’s syndrome patients affected by HSCR
presented a higher incidence of associated CHD than that previ-
ously reported in the overall Down’s syndrome population (mean
40%) (3, 27).
If we do not consider HSCR patients with Down’s syndrome,
CHDs were still present in 3.8% of the study population, which
means that the prevalence of CHDs in isolated HSCR patients is
at least three times that of the general population (5, 7).
On the ground of these considerations, we suggest to investi-
gate all HSCR patients, regardless of sex, length of aganglionosis,
and associated syndromes, in order to exclude a possible associ-
ated cardiac malformation. In particular, we suggest to routinely
perform an ECG and an echocardiogram in all patients admit for
further evaluation and/or treatment of HSCR.
Our institution is known as a referral center in Italy for HSCR
and other intestinal dysganglionoses that could lead to an intrinsic
subsequent risk of selection BIAS. This concern is supported by
the twofolds higher than expected incidence of ultralong forms of
the disease (17.9%). Nonetheless, the prevalence of Down’s syn-
drome (6%) as well as the male to female ratio (4:1) are coherent
with literature data and confirm that our series is representative of
the whole HSCR population.
To conclude, our study demonstrated a higher than previously
reported prevalence of associated cardiac anomalies in HSCR
patients. A better knowledge of clinical phenotype prompted the
implementation of an updated diagnostic algorithm aimed at
improving the outcome and the quality of life of our patients.
In fact, early diagnosis of associated CHDs allows prompt estab-
lishment of adequate treatment and prevention of possible
complications related to a delayed diagnosis.
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